title: Celecoxib induces MRP-4 in lung cancer cells: therapeutic implications.
authors: Angela
authors: A
authors: Gradilone
authors: Fabio Maria
authors: FM
authors: Pulcinelli
authors: Lavinia Vittoria
authors: LV
authors: Lotti
authors: Simone
authors: S
authors: Martino
authors: Teresa
authors: T
authors: Mattiello
authors: Luigi
authors: L
authors: Frati
authors: Anna Maria
authors: AM
authors: Aglianò
authors: Paola
authors: P
authors: Gazzaniga
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000068579:Celecoxib; D045744:Cell Line, Tumor; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D019008:Drug Resistance, Neoplasm; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics* / Q000378:metabolism* / Q000628:therapy; D027425:ATP-Binding Cassette, Sub-Family C Proteins / Q000096:biosynthesis*; D011720:Pyrazoles / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*
chemical_list: D000068579:Celecoxib; D016861:Cyclooxygenase Inhibitors; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D011720:Pyrazoles; D013449:Sulfonamides; C073492:ABCC4 protein, human